Loading company…
Vector BioMed supplies lentiviral vector technology to support partners’ clinical studies and commercialization.
Vector BioMed provides lentiviral vectors and a platform to support partners moving medicines into clinical studies and commercialization. Based in Gaithersburg, Maryland, the company was led by CEO Boro Dropulic as of 2023. In January 2023, it raised Series A funding led by Viking Global Investors, with participation from Casdin Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in